Can Ultrasound be Used as a Measure of Muscle Quality? A Validation Study Comparing Ultrasound With MRI and MRS in Older and Younger Persons.
Launched by UNIVERSITY OF EXETER · Feb 6, 2023
Trial Information
Current as of June 19, 2025
Completed
Keywords
ClinConnect Summary
A key hallmark of the natural biology of ageing is a progressive loss of skeletal muscle mass, strength and aerobic capacity, termed 'sarcopenia' (Cruz-Jentoft et al. 2019a). The association between muscle loss (mass and quality) and increased incidence of falls, fractures, metabolic disease and other health complications is well established. Despite exercise and physiotherapy, recovery from these is often incomplete and studies have failed to identify fully effective countermeasures (Reeves et al, 2005). Ways to objectively measure the clinical effectiveness of the countermeasures are also...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Age \<40y or \>50yrs
- Exclusion Criteria:
- • 1. Significant cognitive deficits and the inability to follow directions during assessment.
- • 2. Neurological, neuromuscular, or musculoskeletal disorders that could impair the quality of the muscle. eg. CP, muscular dystrophy or SCI
- • 3. Prosthesis with metalwork, eg. metal work from surgery
- • 4. Aneurysm clip in situ
- • 5. No metal work anywhere, history of metal fragments in eyes, spinal cord or brain.
- • 6. Previous exposure to metal flakes and metallic injury.
- • 7. No external implants; cochlear implant, spinal cord simulator, pacemaker or other implanted electronic devices.
- • 8. Non-removal hearing aids
- • 9. FEMALE ONLY Not pregnant
- • 10. Not claustrophobic
About University Of Exeter
The University of Exeter is a leading research institution in the United Kingdom, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health and medicine. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The University of Exeter aims to translate scientific findings into practical applications that improve patient outcomes and inform public health strategies, fostering collaboration between researchers, healthcare professionals, and community stakeholders to address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, Devon, United Kingdom
Patients applied
Trial Officials
Francis Stephens
Principal Investigator
University of Exeter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials